ASARECA Newsletter Features IFPRI Paper on Agricultural Biotechnology and Commercial Risks

March 1, 2009

The Policy Analysis and Advocacy Programme (PAAP), part of the Association for Strengthening Agricultural Research in Eastern and Central Africa, featured an IFPRI Discussion Paper in the February 2009 issue of its newsletter. The Paper, “Biosafety Decisions and Perceived Commercial Risks: The Role of GM-Free Private Standards,” by IFPRI Research Fellow Guillaume Gruere and Research Analyst Debdatta Sengupta, takes a closer look at the observed discrepancy between real and perceived commercial risks associated with the use of genetically modified (GM) products in developing countries. The authors focus particularly on the effects of GM-free private standards set up by food companies in Europe and other countries on biotechnology and biosafety policy decisions in food-exporting developing countries. To download the paper, visit http://www.ifpri.org/publication/biosafety-decisions-and-perceived-comme…